{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:20:15Z","timestamp":1790799615161,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012163","name":"University of Innsbruck","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012163","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011035","name":"Standortagentur Tirol","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011035","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jsbmb.2019.04.007","type":"journal-article","created":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T10:37:01Z","timestamp":1554547021000},"page":"105358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Identification of the fungicide epoxiconazole by virtual screening and biological assessment as inhibitor of human 11\u03b2-hydroxylase and aldosterone synthase"],"prefix":"10.1016","volume":"192","author":[{"given":"Muhammad","family":"Akram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7452-1130","authenticated-orcid":false,"given":"Melanie","family":"Patt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Kaserer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Temml","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Watcharee","family":"Waratchareeyakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise V.","family":"Kratschmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Haupenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf W.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-2712","authenticated-orcid":false,"given":"Alex","family":"Odermatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9933-8938","authenticated-orcid":false,"given":"Daniela","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jsbmb.2019.04.007_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1289\/ehp.8045","article-title":"Endocrine disrupting contaminants--beyond the dogma","volume":"114","author":"Guillette","year":"2006","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0010","doi-asserted-by":"crossref","first-page":"s110","DOI":"10.2741\/1010","article-title":"Xenoestrogen exposure and mechanisms of endocrine disruption","volume":"8","author":"Singleton","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1155\/2012\/713696","article-title":"Endocrine-disrupting chemicals: associated disorders and mechanisms of action","volume":"2012","author":"De Coster","year":"2012","journal-title":"J. Environ. Public Health"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jbt.20174","article-title":"Mechanisms of cytochrome P450 substrate oxidation: MiniReview","volume":"21","author":"Guengerich","year":"2007","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3999(02)00429-4","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis, neuroendocrine factors and stress","volume":"53","author":"Tsigos","year":"2002","journal-title":"J. Psychosom. Res."},{"issue":"Part B","key":"10.1016\/j.jsbmb.2019.04.007_bib0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jsbmb.2014.10.009","article-title":"Adrenocortical endocrine disruption","volume":"155","author":"Harvey","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0022-4731(88)90167-7","article-title":"Conversion of 11-deoxycorticosterone and corticosterone to aldosterone by cytochrome P-450 11 beta-\/18-hydroxylase from porcine adrenal","volume":"29","author":"Yanagibashi","year":"1988","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0040","first-page":"421","article-title":"Disorders of steroid 11\u03b2-Hydroxylase isozymes*","volume":"15","author":"White","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0045","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.HYP.7.2.204","article-title":"Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension","volume":"7","author":"de Simone","year":"1985","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0050","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"El-Maouche","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0055","doi-asserted-by":"crossref","first-page":"E1933","DOI":"10.1073\/pnas.1621082114","article-title":"Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency","volume":"114","author":"Khattab","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0060","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0950-351X(88)80025-9","article-title":"Molecular genetics of congenital adrenal hyperplasia","volume":"2","author":"White","year":"1988","journal-title":"Baillieres Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mce.2003.11.008","article-title":"Modulation of aldosterone and cortisol synthesis on the molecular level","volume":"215","author":"Lisurek","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0070","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ki.1980.14","article-title":"Hyperkalemia and hyporeninemic hypoaldosteronism","volume":"17","author":"DeFronzo","year":"1980","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0075","first-page":"3525","article-title":"Hereditary defect in biosynthesis of aldosterone: aldosterone synthase deficiency 1964-1997","volume":"82","author":"Peter","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0080","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1073\/pnas.89.11.4996","article-title":"Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency","volume":"89","author":"Pascoe","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0085","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/0006-291X(92)91827-D","article-title":"Congenitally defective aldosterone biosynthesis in humans: the involvement of point mutations of the P-450C18 gene (CYP11B2) in CMO II deficient patients","volume":"182","author":"Mitsuuchi","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0162-0134(01)00331-2","article-title":"Modelling of three-dimensional structures of cytochromes P450 11B1 and 11B2","volume":"87","author":"Belkina","year":"2001","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0095","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0022-4731(89)90384-1","article-title":"Inhibition of human adrenal steroidogenic enzymes in vitro by imidazole drugs including ketoconazole","volume":"32","author":"Ayub","year":"1989","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-0773.1998.tb01473.x","article-title":"Structure-activity relationship for inhibition of CYP11B1-dependent glucocorticoid synthesis in Y1 cells by aryl methyl sulfones","volume":"83","author":"Johansson","year":"1998","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0887-2333(01)00111-4","article-title":"Effects of 3-MeSO2-DDE and some CYP inhibitors on glucocorticoid steroidogenesis in the H295R human adrenocortical carcinoma cell line","volume":"16","author":"Johansson","year":"2002","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0110","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.chemosphere.2005.08.013","article-title":"Effects of PCBs and MeSO2\u2013PCBs on adrenocortical steroidogenesis in H295R human adrenocortical carcinoma cells","volume":"63","author":"Xu","year":"2006","journal-title":"Chemosphere"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.beem.2005.09.006","article-title":"Effects of endocrine-disrupting chemicals on adrenal function","volume":"20","author":"Hinson","year":"2006","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"183","key":"10.1016\/j.jsbmb.2019.04.007_bib0120","first-page":"57859","article-title":"Endocrine disruption potential of drugs: nonclinical evaluation, Draft Guidance","volume":"78","author":"FDA","year":"2013","journal-title":"Fed. Regist."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jsbmb.2014.10.009","article-title":"Adrenocortical endocrine disruption","volume":"155","author":"Harvey","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jsbmb.2013.04.009","article-title":"In silico methods in the discovery of endocrine disrupting chemicals","volume":"137","author":"Vuorinen","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0135","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10822-006-9066-y","article-title":"High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening","volume":"20","author":"Steindl","year":"2006","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jsbmb.2017.03.008","article-title":"Virtual screening applications in short-chain dehydrogenase\/reductase research","volume":"171","author":"Beck","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0145","doi-asserted-by":"crossref","first-page":"22799","DOI":"10.3390\/molecules201219880","article-title":"Pharmacophore models and pharmacophore-based virtual screening: concepts and applications exemplified on hydroxysteroid dehydrogenases","volume":"20","author":"Kaserer","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0150","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.2174\/092986708785132843","article-title":"Enhancing drug discovery through in silico screening: strategies to increase true positives retrieval rates","volume":"15","author":"Kirchmair","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0155","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nrd941","article-title":"Integration of virtual and high-throughput screening","volume":"1","author":"Bajorath","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0160","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1021\/jm301844q","article-title":"Modulation of cytochromes P450 with xanthone-based molecules: from aromatase to aldosterone synthase and steroid 11\u03b2-Hydroxylase inhibition","volume":"56","author":"Gobbi","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0165","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1021\/jm800683c","article-title":"Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approach","volume":"51","author":"Lucas","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0170","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1021\/jm101470k","article-title":"Fine-tuning the selectivity of aldosterone synthase inhibitors: structure\u2212activity and structure\u2212selectivity insights from studies of heteroaryl substituted 1,2,5,6-Tetrahydropyrrolo[3,2,1-ij]quinolin-4-one derivatives","volume":"54","author":"Lucas","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bmcl.2005.09.059","article-title":"Development and evaluation of a pharmacophore model for inhibitors of aldosterone synthase (CYP11B2)","volume":"16","author":"Ulmschneider","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0180","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2017.00104","article-title":"Pharmacophore modeling and in Silico\/in vitro screening for human cytochrome P450 11B1 and cytochrome P450 11B2 inhibitors","volume":"5","author":"Akram","year":"2017","journal-title":"Front. Chem."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/minf.201300063","article-title":"Pharmacophore model refinement for 11\u03b2-Hydroxysteroid dehydrogenase inhibitors: search for modulators of intracellular glucocorticoid concentrations","volume":"33","author":"Vuorinen","year":"2014","journal-title":"Mol. Inform."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0190","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1021\/jm030896t","article-title":"Improving structure-based virtual screening by multivariate analysis of scoring data","volume":"46","author":"Jacobsson","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0195","series-title":"Pipeline Pilot","author":"Accelrys","year":"2011"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0200","series-title":"Molecular Operating Environment (MOE)","author":"C.C.G. Inc","year":"2011"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0205","series-title":"Discovery Studio, Biovia","author":"Accelrys","year":"2015"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0210","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1021\/ci300314k","article-title":"Conformer generation with OMEGA: learning from the data set and the analysis of failures","volume":"52","author":"Hawkins","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0215","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer generation with OMEGA: algorithm and validation using high quality structures from the protein databank and Cambridge structural database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0220","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/07435809509030460","article-title":"Cloning of CYP11B1 and CYP11B2 from normal human adrenal and their functional expression in COS-7 and V79 Chinese hamster cells","volume":"21","author":"Denner","year":"1995","journal-title":"Endocr. Res."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0225","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0960-0760(02)00056-0","article-title":"Development of a test system for inhibitors of human aldosterone synthase (CYP11B2): screening in fission yeast and evaluation of selectivity in V79 cells","volume":"81","author":"Ehmer","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0230","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/ml100071j","article-title":"First selective CYP11B1 inhibitors for the treatment of cortisol-dependent diseases","volume":"2","author":"Hille","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0235","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0960-0760(00)00137-0","article-title":"Development of a simple and rapid assay for the evaluation of inhibitors of human 17alpha-hydroxylase-C(17,20)-lyase (P450cl7) by coexpression of P450cl7 with NADPH-cytochrome-P450-reductase in Escherichia coli","volume":"75","author":"Ehmer","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0240","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14756360310001640913","article-title":"Synthesis of hydroxy derivatives of highly potent non-steroidal CYP 17 inhibitors as potential metabolites and evaluation of their activity by a non cellular assay using recombinant human enzyme","volume":"19","author":"Hutschenreuter","year":"2004","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0245","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tox.2017.02.010","article-title":"Steroid profiling in H295R cells to identify chemicals potentially disrupting the production of adrenal steroids","volume":"381","author":"Strajhar","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0250","doi-asserted-by":"crossref","first-page":"12374","DOI":"10.1111\/jne.12374","article-title":"Acute effects of lysergic acid diethylamide on circulating steroid levels in healthy subjects","volume":"28","author":"Strajhar","year":"2016","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0255","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1021\/acs.jafc.6b00325","article-title":"Discovery of potent succinate-ubiquinone oxidoreductase inhibitors via pharmacophore-linked fragment virtual screening approach","volume":"64","author":"Xiong","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0260","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1210\/me.2012-1287","article-title":"Structural insights into aldosterone synthase substrate specificity and targeted inhibition","volume":"27","author":"Strushkevich","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-2836(95)80037-9","article-title":"Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation","volume":"245","author":"Jones","year":"1995","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0270","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking1","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0275","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/prot.10465","article-title":"Improved protein-ligand docking using GOLD","volume":"52","author":"Verdonk","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0280","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0285","series-title":"OECD Guideline for the Testing of Chemicals. Test No. 456: H295R Steroidogenesis Assay","author":"OECD","year":"2011"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0290","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1097\/HJH.0b013e32833b1f8e","article-title":"Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve L-type calcium channels","volume":"28","author":"Clerc","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0295","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1021\/jm500140c","article-title":"Novel pyridyl- or isoquinolinyl-substituted indolines and indoles as potent and selective aldosterone synthase inhibitors","volume":"57","author":"Yin","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0300","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1747-0285.2010.01038.x","article-title":"Synthesis, molecular docking, and biological evaluation of novel triazole derivatives as antifungal agents","volume":"76","author":"Guan","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0305","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.ejmech.2008.11.007","article-title":"Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14\u03b1-demethylase","volume":"44","author":"Chai","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0968-0004(99)01493-0","article-title":"Multiple physiological functions for multidrug transporter P-glycoprotein?","volume":"25","author":"Johnstone","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0315","series-title":"Draft Assessment Report (DAR) Conclusion on the Peer Review of the Pesticide Risk Assessment of the Active Substance Flurprimidol","first-page":"1962","author":"EFSA","year":"2011"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0320","series-title":"R.E.D FACTS Ancymidol, to Pesticide Docket, Public Response and Program Resources Branch, Field Operations Division (7506C), Office of Pesticide Programs (OPP), US EPA, Washington, DC 20460, US Environmental Protection Agency","author":"U.S.E.P.A.A.D. Ancymidol","year":"1995"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0325","series-title":"Endocrine Disruptors: Study on Gathering Information on 435 Substances with Insufficient Data","author":"E. Commission","year":"2002"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0330","series-title":"EPA Pesticides Fact Sheet, United States Environmental Protection Agency Office of Prevention","author":"EPA","year":"2006"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0335","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1289\/ehp.5785","article-title":"Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase","volume":"111","author":"Zarn","year":"2003","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0340","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/taap.2002.9420","article-title":"Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells","volume":"182","author":"Sanderson","year":"2002","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0345","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.taap.2013.01.033","article-title":"The relevance of chemical interactions with CYP17 enzyme activity: assessment using a novel in vitro assay","volume":"268","author":"Roelofs","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0350","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/10408444.2013.855163","article-title":"Human and ecological risk assessment of a crop protection chemical: a case study with the azole fungicide epoxiconazole","volume":"44","author":"Chambers","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0355","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/toxsci\/kfm227","article-title":"Endocrine-disrupting activities in vivo of the fungicides tebuconazole and epoxiconazole","volume":"100","author":"Taxvig","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0360","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.reprotox.2010.07.009","article-title":"Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticals","volume":"30","author":"Kj\u00e6rstad","year":"2010","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0365","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0887-2333(00)00018-7","article-title":"Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitro","volume":"14","author":"Vinggaard","year":"2000","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0370","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1081\/ERC-200035093","article-title":"Comparative assessment of the inhibition of recombinant human CYP19 (Aromatase) by azoles used in agriculture and as drugs for humans","volume":"30","author":"Tr\u00f6sken","year":"2004","journal-title":"Endocr. Res."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0375","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.bcp.2009.12.005","article-title":"The UV-filter benzophenone-1 inhibits 17\u03b2-hydroxysteroid dehydrogenase type 3: Virtual screening as a strategy to identify potential endocrine disrupting chemicals","volume":"79","author":"Nashev","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0380","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/ml100283h","article-title":"Optimization of the first selective Steroid-11\u03b2-hydroxylase (CYP11B1) inhibitors for the treatment of cortisol dependent diseases","volume":"2","author":"Hille","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0385","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1021\/jm400484p","article-title":"Highly potent and selective nonsteroidal dual inhibitors of CYP17\/CYP11B2 for the treatment of prostate Cancer To reduce risks of cardiovascular diseases","volume":"56","author":"Pinto-Bazurco Mendieta","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2019.04.007_bib0390","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1021\/jm101470k","article-title":"Fine-tuning the selectivity of aldosterone synthase inhibitors: structure\u2212Activity and structure\u2212Selectivity insights from studies of heteroaryl substituted 1,2,5,6-Tetrahydropyrrolo[3,2,1-ij]quinolin-4-one derivatives","volume":"54","author":"Lucas","year":"2011","journal-title":"J. Med. Chem."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076018307763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076018307763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:02:43Z","timestamp":1760745763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076018307763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":78,"alternative-id":["S0960076018307763"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.04.007","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of the fungicide epoxiconazole by virtual screening and biological assessment as inhibitor of human 11\u03b2-hydroxylase and aldosterone synthase","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105358"}}